Summary
Indwelling urinary catheters play a very important part in urology. However, their use is accompanied by a considerable increase in the risk of nosocomial urinary tract infections. The pathophysiological cause is ascribed to pathogens that adhere to the catheter surface, proliferate and produce a biofilm. In addition to aseptic techniques, modification of the catheter material to confer antimicrobial activity plays an essential part in the prevention of catheter-related urinary tract infections. The antimicrobial efficacy of silver against gram-positive and gram-negative bacteria is well known and amply shownin vitro. The efficacy of silver-impregnated catheters is critically dependent on both the chemical structure of the incorporated silver and the way the silver has been combined with the basic catheter material. Hence, clinical studies on silver-modified catheters have so far given inconsistent results. The new technology of the Erlanger silver catheter offers the opportunity of an effective reduction in catheter-related infections.
Similar content being viewed by others
References
Nosokomiale Infektionen in Deutschland—Erfassung und Prävalenz (NIDEP-Studie): Band 56, Schriftenreihe des Bundesministeriums für Gesundheit. Nomos Verlagsgesellschaft, Baden-Baden 1995.
Garibaldi, R. A.: Hospital acquired urinary tract infections. In:Wenzel, R. (eds.): Trevention and control of nosocomial infections. Williams & Wilkins, Baltimore 1997, pp. 600–615.
Tambyah, P. A.: SHEA Conference 1997, abstr. M48.
Stamm, W. E.: Catheter-associated urinary tract infections: epidemiology, pathogenicity, and prevention. Am. J. Med. 91 (1991) 865–871.
Reid, G., Mei, H. C., Busscher, H. J.: Microbial biofilms and urinary tract infections. In:Brumfitt, W. Hamilton-Miller, J. M., Bailey, R. R. (eds.): Urinary tract infections. Campman & Hall Medical, 1998, pp. 111–116.
Naber, K. G.: Rationale Diagnostik und Therapie von Harnwegs-infektionen. Urologe B 37 (1997) 328–334.
Edin-Liljegren, A., Grenabo, L., Hedelin, H., Pettersson, S., Wang, Y. H.: Long-term studies of urease induced crystallisation in human urine. J. Urol. 152 (1994) 208–212.
NNIS-Report. Am. J. Infect. Control 25 (1997) 477–487.
Centers for Disease Control: Guidelines for prevention of catheterassociated urinary tract infections 1998.
Stark, R. P., Maki, D.: Bacteriuria in the catheterized patient. What quantitative level of bacteriuria is relevant? N. Engl. J. Med. 311 (1984) 560–564.
Definitionen nosokomialer Infektionen (CDC-Definitionen): Robert-Koch-Institut, Berlin 1998.
Warren, J. W., Tenney, J. H., Hoopes, J. M., Muncie, H. L., Anthony, W. C.: A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J. Infect. Dis. 146 (1982) 719–723.
Butler, H. K., Kranin, C.M.: Evaluation of polymyxin catheter lubricant and impregnated catheters. J. Urol. 100 (1968) 560–566.
Desautels, R. E., Walter, C. W., Graves, R. C., Harrison, J. H.: Technical advances in the prevention of urinary tract infection. J. Urol. 87 (1962) 487.
Guggenbichler, J.-P., Böswald, M., Lugauer, S., Krall, T.: A new technology of microdispersed silver in polyurethane induces antimicrobial activity in central venous catheters. Infection 27 (Suppl. 1) (1999) S 16–23.
Zhao, G., Stevens, S. E.: Multiple parameters for the comprehensive evaluation of the susceptibility ofEscherichia coli to the silver ion. Biometals 11 (1998) 27–32.
Gabriel, M. M., Sawant, A. D., Simmons, R. B., Ahearn, D. G.: Effects of silver on adherence of bacteria to urinary catheters:in vitro studies. Curr. Microbiol. 30 (1995) 17–22.
Gabriel, M. M., Mayo, M. S., May, L. L., Simmson, R. B., Ahearn, D. G.:In vitro evaluation of the efficacy of a silver-coated catheter. Curr. Microbiol. 33 (1996) 1–5.
Wuhrmann, K., Zobrist, F.: Untersuchungen über die bakterizide Wirkung von Silber in Wasser. Schweiz. Z. Hydrol. 20 (1958) 218–254.
Li, X. Z., Nikaido, H., Williams, K. E.: Silver-resistant mutants ofEscherichia coli display active efflux of the Ag+ and are deficient in porins. J. Bacteriol. 179 (1997) 6127–6132.
Deshpande, L. M., Chopade, B. A.: Plasmid mediated silver resistance inAcinetobacter baumannii. Biometals 7 (1994) 49–56.
Starodub, M. E., Trevors, J. T.: Silver accumulation and resistance inEscherichia coli. R1. J. Inorg. Biochem. 39 (1994) 317–325.
Stickler, D. J., Morris, N. S., Williams, T. J.: An assessment of the ability of a silver-releasing device to prevent bacterial contamination of urethral catheter drainage systems. Br. J. Urol. 78 (1996) 579–588.
Lundeberg, T.: Prevention of catheter associated urinary infections by use of silver-impregnated catheters. Lancet ii (1986) 1031.
Liedberg, H., Lundeberg, T.: Silver alloy coated catheters reduce catheter-associated bacteriuria. Br. J. Urol. 65 (1990) 379–381.
Liedberg, H., Lundeberg, T., Ekman, P.: Refinements in the coating of urethral catheters reduce the incidence of catheter-associated bacteriuria. An experimental and clinical study. Eur. Urol. 17 (1990) 379–381.
Liedberg, H., Lundeberg, T.: Prospective study of incidence of urinary tract infections in patients catheterized with bard hydrogel and silver-coated catheters or bard hydrogel-coated catheters. J. Urol. 149 (1992) 405A (abstr.).
Riley, D. K., Classen, D. C., Stevens, L. E., Burke, J. P.: A large randomized clinical trial of a silver impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. Am. J. Med. 98 (1995) 349–356.
Johnson, J. R., Roberts, P. L., Olsen, R. J., Moyer, K. A., Stamm, W. E.: Prevention of catheter-associated urinary tract infection with a silver oxide-coated urinary catheter: clinical and microbiologic correlates. J. Infect. Dis. 162 (1990) 1145–1150.
Saint, S., Elmore, J. G., Sullivan, S. D., Emmerson, S. S., Koepsell, T. D.: The efficacy of silver alloy coated urinary catheters in preventing urinary tract infection: a meta analysis. Am. J. Med. 105 (1998) 236–241.
Takeuchi, H., Hida, S., Yoshida, O., Ueda, T.: Clinical study on efficacy of a foley catheter coated with silver-protein in prevention of urinary tract infections. Hinyokika Kiyo 39 (1993) 293–298.
Nakada, J., Kawahara, M., Onodera, S., Oishi, Y.: Clinical study of silver lubricant foley catheter. Hinyokika Kiyo 42 (1996) 433–438.
Konishi, T., Tomoyoshi, T., Johnin, K.: Electron microscopic study on the surface of long-term indwelling silver-protein-coated urethral catheters. Hinyokika Kiyo 43 (1997) 19–23.
Morris, N. S., Stickler, D. J., Winters, C.: Which indwelling urethral catheters resist encrustation byProteus mirabilis biofilms? Br. J. Urol. 80 (1997) 58–63.
Haacke, C., Schierholz, J., Timpe, K.: Neue Materialien zur Harnleiterschienung—Mythen und Fakten. Urologe B 37 (1997) 243–246.
Böswald, M., Lugauer, S., Regenfus, A., Braun, G. G., Martus, P., Geis, C., Scharf, J., Bechert, T., Greil, J., Guggenbichler, J.-P.: Reduced rates of catheter-associated infections by use of a new silver-impregnated central venous catheter. Infection 27 (Suppl. 1) (1999) S 56–59.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rösch, W., Lugauer, S. Catheter-associated infections in urology: Possible use of silver-impregnated catheters and the erlanger silver catheter. Infection 27 (Suppl 1), S74–S77 (1999). https://doi.org/10.1007/BF02561624
Issue Date:
DOI: https://doi.org/10.1007/BF02561624